A Study of the Pan-KRAS Inhibitor LY4066434 in Participants With KRAS Mutant Solid Tumors
Eli Lilly and Company
Eli Lilly and Company
Jazz Pharmaceuticals
Arcus Biosciences, Inc.
Seagen Inc.
Taiho Oncology, Inc.
University of Rochester
University Hospital Schleswig-Holstein